Clinical Trial Update: Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction total parenteral nutrition followed by nivolumab and radiation for locoregionally advanced laryngeal and hypopharyngeal cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Hypopharyngeal Cancer
• Laryngeal Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-12-20